Updates in the Treatment of HER2+ and HER2-Low Breast Cancer
home / peer-exchange / updates-in-the-treatment-of-her2-positive-and-her2-low-breast-cancer
Expert oncologists Andy Seidman, MD; Vijayakrishna Gadi, MD, PhD; Tiffany Traina, MD; William Gradishar, MD; and Stephanie Graff, MD, review data from ASCO 2022 and share updates in the management of HER2+ and HER2-low breast cancer.